
Regeneron's Livsayis (cemdisiran) gains FDA approval for adults with antibody-positive generalized myasthenia gravis, dosed four times a year.
WOTY-How the Award has changed the face of the industry.
HBA’s CEO Laurie Cooke teams up with HBA President Ceci Zak, Vice President of general therapeutics for sanofi-aventis, to share how the Woman of the Year Award has changed the face of industry. PLUS: Ceci recounts how HBA has allowed her to “dream a dream”—one that she didn’t even know she had.






